You are here

Home » Content

Ürolitiyazisli çocuk hastaların demografik özellikleri ve tedavi yaklaşımlarının değerlendirilmesi

Evaluation of demographic aspects and management of pediatric urolithiasis patients

Journal Name:

  • Gülhane Tıp Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Urolithiasis has an endemic pattern in developing countries, including ours. The aims of this study were to retrospectively assess the demographic aspects of our patients with urolithiasis, to review associated structural urinary system anomalies and metabolic factors and to evaluate the management strategies. Thirty seven patients with urolithiasis followed at our clinic were, thus, retrospectively analyzed. There was no significant difference among the patients with respect to gender (51.3% female, 48.6% male). Mean age of the patients was 7.2 years (range 3 to 12). Structural urinary system anomalies were detected in 5 (13.5%) of the patients. Of the predisposing factors, metabolic conditions, although statistically insignificant, were the most common (in 17 patients, 45.9%). Interventional therapeutic procedures were performed in 4 (10.8%) patients (nephrolithotomy in two patients, pyelolithotomy in one patient and ureterolithotomy in one patient). The other patients were controlled by medical treatment and metaphylaxis planned according to the metabolic test results. Recurrence rate of the disease was 2.7%. Our findings were in correlation with the literature except for the decreased incidence of associated anatomical anomalies. We conclude that metaphylactic measures and metabolic analyses were sufficient in the management of most of our pediatric patients with urolithiasis.
Bookmark/Search this post with
Abstract (Original Language): 
Ürolitiyazis ülkemiz de dahil olmak üzere özellikle gelişmekte olan ülkelerde endemik bir hastalıktır. Amacımız kliniğimizde takip ettiğimiz üriner sistem taş hastalarımızın demografik özelliklerini, eşlik eden yapısal üriner sistem anomalileri ile metabolik faktörleri gözden geçirmek ve tedavi yöntemlerini retrospektif olarak değerlendirmektir. Bu amaçla kliniğimizde takip edilen ürolitiyazis tanılı 37 hasta retrospektif olarak incelendi. Olgular arasında cinsiyet dağılımında belirgin bir farklılık saptanmadı (%51.3 kız, %48.6 erkek). Yaş ortalaması 7.2 idi (hastaların yaşları 3 ile 12 arasında değişiyordu). Beş hastada (%13.5) yapısal üriner sistem anomalisi saptandı. Diğer predispozan faktörlerden metabolik faktörler, istatistiksel olarak anlamlı olmamakla birlikte en yüksek yüzde ile 17 hastada (%45.9) tespit edildi. Tedavi olarak girişimsel yöntemler sadece 4 hastaya (iki hastaya nefrolitotomi, bir hastaya piyelolitotomi, bir hastaya üreterolitotomi) (%10.8) uygulandı. Diğer hastalar ise metabolik test sonuçlarına yönelik metafilaktik diyet ve medikal tedavilerle kontrol altına alındı. Hastalığın nüks oranı %2.7 idi. Eşlik eden anatomik anormallik oranının düşük olması dışında diğer bulgularımız literatür ile uyumluydu. Sonuçta çocukluk çağı taş hastalarımızın çoğunda metafilaktik önlemler ve metabolik analizler ile tedavinin yönlendirilebildiği görülmüştür.
FULL TEXT (PDF): 
PDF icon arastirmax-urolitiyazisli-cocuk-hastalarin-demografik-ozellikleri-tedavi-yaklasimlarinin-degerlendirilmesi.pdf
  • 3
137-140
  • Turkish

REFERENCES

References: 

1. Yoshida O, Okada Y. Epidemiology of urolithiasis in
Japan: a chronological and geographical study. Urol Int
1990; 45: 104-111.
2. Rizvi SA, Naqvi SA, Hussain Z, et al. Pediatric urolithiasis: developing nation perspectives. J Urol 2002; 168:
1522-1525.
3. Pietrow PK, Pope JC 4th, Adams MC, Shyr Y, Brock JW
3rd. Clinical outcome of pediatric stone disease. J Urol
2002; 167: 670-673.
4. Stapleton FB. Childhood stones. Endocrinol Metab Clin
North Am 2002; 31: 1001-1015.
5. Milliner DS. Urolithiasis. In: Avner ED, Harmon WE,
Niaudet P (eds). Pediatric Nephrology. Philadelphia:
Lippincott Williams & Wilkins, 2004: 1091-1111.
6. Faerber GJ. Pediatric urolithiasis. Curr Opin Urol 2001;
11: 385-389.
7. Sarica K. Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res 2006; 34: 96-
101.
8. Coward RJ, Peters CJ, Duffy PG, et al. Epidemiology of
paediatric renal stone disease in the UK. Arch Dis Child140 · Eylül 2007 · Gülhane TD Sakallýoðlu ve ark.
2003; 88: 962-965.
9. Ozokutan BH, Kucukaydin M, Gunduz Z, et al. Urolithiasis in childhood. Pediatr Surg Int 2000; 16: 60-63.
10. Alon US, Zimmerman H, Alon M. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited. Pediatr
Nephrol 2004; 19: 516-520.
11. Cameron MA, Pak CYC. Approach to the patient with the
episode of nephrolithiasis. Clin Rev Bone Miner Metab
2004; 2: 265-278.
12. Pak CY, Waters O, Arnold L, Holt K, Cox C, Barilla D.
Mechanism for calcium urolithiasis among patients with
hyperuricosuria: supersaturation of urine with respect to
monosodium urate. J Clin Invest 1977; 59: 426-431.
13. Pak CY, Arnold LH. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp
Biol Med 1975; 149: 930-932.
14. Zerwekh JE, Holt K, Pak CY. Natural urinary macromolecular inhibitors: attenuation of inhibitory activity by
urate salts. Kidney Int 1983; 23: 838-841.
15. Jungers P, Joly D, Barbey F, Choukroun G, Daudon M.
ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 2004; 44: 799-
805.
16. Choi H, Snyder HM 3rd, Duckett JW. Urolithiasis in
childhood: current management. J Pediatr Surg 1987; 22:
158-164.
17. Gearhart JR, Herzberg GZ, Jeffs RD. Childhood urolithiasis: experiences and advances. Pediatrics 1991; 87: 445-
450.
18. Polinsky MS, Kaiser BA, Baluarte HJ. Urolithiasis in
childhood. Pediatr Clin North Am 1987; 34: 683-687.
19. Cameron MA, Sakhaee K, Moe OW. Nephrolithiasis in
children. Pediatr Nephrol 2005; 20: 1587-1592.
20. Cameron JS, Moro F, Simmonds HA. Gout, uric acid and
purine metabolism in paediatric nephrology. Pediatr
Nephrol 1993; 7: 105-118.
21. Cohen TD, Ehreth J, King LR, Preminger GM. Pediatric
urolithiasis: medical and surgical management. Urology
1996; 47: 292-303.
22. Milliner DS, Murphy ME. Urolithiasis in pediatric
patients. Mayo Clin Proc 1993; 68: 241-248.
23. Perrone HC, dos Santos DR, Santos MV, et al.
Urolithiasis in childhood: metabolic evaluation. Pediatr
Nephrol 1992; 6: 54-56.

Thank you for copying data from http://www.arastirmax.com